MX2017011774A - Forma de dosificacion dispersable. - Google Patents

Forma de dosificacion dispersable.

Info

Publication number
MX2017011774A
MX2017011774A MX2017011774A MX2017011774A MX2017011774A MX 2017011774 A MX2017011774 A MX 2017011774A MX 2017011774 A MX2017011774 A MX 2017011774A MX 2017011774 A MX2017011774 A MX 2017011774A MX 2017011774 A MX2017011774 A MX 2017011774A
Authority
MX
Mexico
Prior art keywords
dosage form
dispersible dosage
dispersible
ready
produced
Prior art date
Application number
MX2017011774A
Other languages
English (en)
Inventor
A C Gane Patrick
Schoelkopf Joachim
E Gerard Daniel
Puchkov Maxim
Huwyler Joerg
Stirnimann Tanja
Wagner Hattler Leonie
Diaz Quijano Carolina
Original Assignee
Omya Int Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omya Int Ag filed Critical Omya Int Ag
Publication of MX2017011774A publication Critical patent/MX2017011774A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2068—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
    • C01F11/00—Compounds of calcium, strontium, or barium
    • C01F11/18—Carbonates
    • C01F11/185—After-treatment, e.g. grinding, purification, conversion of crystal morphology
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/10—Solid density
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/12—Surface area
    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01P—INDEXING SCHEME RELATING TO STRUCTURAL AND PHYSICAL ASPECTS OF SOLID INORGANIC COMPOUNDS
    • C01P2006/00—Physical properties of inorganic compounds
    • C01P2006/14—Pore volume

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Geology (AREA)
  • Medicinal Preparation (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Cosmetics (AREA)
  • Seasonings (AREA)

Abstract

La presente invención proporciona un método para mejorar la capacidad de flujo y la densidad de un material a granel sin compactar, de un material que comprende carbonato de calcio natural y/o sintético, funcionalizado, al uso de tal material mejorado en gránulos listo para su uso y a las formas de dosificación dispersables producidas a partir de los mismos.
MX2017011774A 2015-03-20 2016-03-15 Forma de dosificacion dispersable. MX2017011774A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP15160194.5A EP3069713A1 (en) 2015-03-20 2015-03-20 Dispersible dosage form
US201562203948P 2015-08-12 2015-08-12
PCT/EP2016/055590 WO2016150773A1 (en) 2015-03-20 2016-03-15 Dispersible dosage form

Publications (1)

Publication Number Publication Date
MX2017011774A true MX2017011774A (es) 2017-12-04

Family

ID=52686285

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017011774A MX2017011774A (es) 2015-03-20 2016-03-15 Forma de dosificacion dispersable.

Country Status (16)

Country Link
US (1) US10617648B2 (es)
EP (2) EP3069713A1 (es)
JP (1) JP2018510162A (es)
KR (1) KR102119074B1 (es)
CN (1) CN107405308A (es)
AU (1) AU2016236390A1 (es)
BR (1) BR112017019927A2 (es)
CA (1) CA2978032C (es)
CO (1) CO2017009959A2 (es)
CR (1) CR20170427A (es)
MX (1) MX2017011774A (es)
PH (1) PH12017501546A1 (es)
RU (1) RU2733757C2 (es)
SG (1) SG11201707719WA (es)
TW (1) TW201641120A (es)
WO (1) WO2016150773A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3260115A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3260114A1 (en) * 2016-06-21 2017-12-27 Omya International AG Method for the production of a dosage form
EP3311665A1 (en) * 2016-10-21 2018-04-25 Omya International AG Use of surface-reacted calcium carbonate for preparing supersaturated aqueous systems
CN107255602B (zh) * 2017-06-06 2020-05-05 武汉烽火锐拓科技有限公司 在线测量疏松体密度的方法及装置
CA3068308A1 (en) * 2017-06-29 2019-01-03 Solenis Technologies Cayman, L.P. Water stable granules and tablets
JP6719779B2 (ja) * 2017-07-27 2020-07-08 白石工業株式会社 炭酸カルシウムを含む食品
JP6959669B2 (ja) * 2017-07-27 2021-11-02 白石工業株式会社 炭酸カルシウム、食品添加用炭酸カルシウム製剤及び食品
TW202200206A (zh) 2020-04-28 2022-01-01 瑞士商歐米亞國際公司 包含表面反應碳酸鈣作為賦形劑之顆粒

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5512411B2 (es) 1974-03-12 1980-04-02
US4451260A (en) 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
US4985459A (en) 1984-02-08 1991-01-15 Richardson-Vicks, Inc. Analgesic and anti-inflammatory compositions comprising diphenhydramine and methods of using same
JPS6143108A (ja) 1984-08-03 1986-03-01 Nippon Shinyaku Co Ltd 医薬品製剤及びその製造法
PL149493B1 (en) 1985-04-12 1990-02-28 Method of obtaining a tablet capable to buoy over surface of gastric juice
US4627977A (en) 1985-09-13 1986-12-09 Colgate-Palmolive Company Anticalculus oral composition
GB8809421D0 (en) 1988-04-21 1988-05-25 Fordonal Sa Antacid compositions with prolonged gastric residence time
DE69428707T2 (de) 1993-08-20 2002-07-11 Nippon Shinyaku Co Ltd Im magen verbleibende zubereitung, quellender formkörper und herstellungsverfahren
US5939091A (en) * 1997-05-20 1999-08-17 Warner Lambert Company Method for making fast-melt tablets
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
US6582738B2 (en) 1999-09-13 2003-06-24 Deseret Laboratories, Inc. Process for preparing chewing gum containing a nutritional supplement
AU2001284444B2 (en) 2000-09-06 2006-05-25 Mitsubishi Tanabe Pharma Corporation Preparations for oral administration
US20030157213A1 (en) 2002-02-19 2003-08-21 Jeffrey Jenkins Nutrient chewing gum
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2881957B1 (fr) 2005-02-16 2008-08-08 Solvay Comprimes comprenant une substance biologiquement active et un excipient
FI20061146A0 (fi) * 2006-11-10 2006-12-21 Iprbox Oy Rakeita, tabletteja ja rakeistusmenetelmä
PT2070991E (pt) 2007-12-12 2010-10-25 Omya Development Ag Processo para produção de carbonato de cálcio precipitado reagido em superfície
EP2168572A1 (en) 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
ME01449B (me) 2009-06-15 2014-04-20 Omya Development Ag POSTUPAK ZA DOBIJANJE POVRŠINSKI IZREAGOVANOG KALCIJUM KARBONATA l NJEGOVA UPOTREBA
ATE545682T1 (de) 2009-06-15 2012-03-15 Omya Development Ag Verfahren zur herstellung eines an der oberfläche reagierten calciumcarbonats, das eine schwache säure anwendet
CN102665764A (zh) * 2009-12-22 2012-09-12 Fmc有限公司 可用作可再压实药物赋形剂的微晶纤维素和碳酸钙组合物
EP2679638B1 (en) 2012-06-28 2015-09-02 Omya International AG High solids aqueous mineral and/or filler and/or pigment suspension in acidic pH environment
EP2719376B1 (en) 2012-10-12 2015-03-04 Omya International AG Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
ES2628371T3 (es) 2012-10-12 2017-08-02 Omya International Ag Formulación de forma farmacéutica sólida de disgregación rápida que comprende carbonato de calcio funcionalizado y método para su fabricación
EP2997833B1 (en) * 2014-09-22 2018-01-31 Omya International AG Surface-reacted calcium carbonate for use as anti-caking agent
EP3034070A1 (en) * 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system

Also Published As

Publication number Publication date
CN107405308A (zh) 2017-11-28
KR20170129232A (ko) 2017-11-24
RU2733757C2 (ru) 2020-10-06
CA2978032A1 (en) 2016-09-29
KR102119074B1 (ko) 2020-06-05
CA2978032C (en) 2020-09-01
CO2017009959A2 (es) 2018-01-05
JP2018510162A (ja) 2018-04-12
US10617648B2 (en) 2020-04-14
AU2016236390A1 (en) 2017-11-09
SG11201707719WA (en) 2017-10-30
RU2017134394A3 (es) 2019-04-03
BR112017019927A2 (pt) 2018-06-12
CR20170427A (es) 2018-04-02
TW201641120A (zh) 2016-12-01
RU2017134394A (ru) 2019-04-03
EP3069713A1 (en) 2016-09-21
WO2016150773A1 (en) 2016-09-29
EP3270899A1 (en) 2018-01-24
US20180078506A1 (en) 2018-03-22
PH12017501546A1 (en) 2018-02-05

Similar Documents

Publication Publication Date Title
PH12017501546A1 (en) Dispersible dosage form
PH12018500707A1 (en) Anti-human cd19 antibodies with high affinity
MX2017004579A (es) Estructuras fibrosas solubles y metodos para fabricarlas.
SG10201803042PA (en) Anti-tim-3 antibodies
PH12016501441A1 (en) Chimeric alkaline phosphate-like proteins
MX2017001281A (es) Material anisotropico biocompuesto, implantes medicos que lo comprenden y metodos para el tratamiento del mismo.
MX2020005213A (es) Inhibidores de proteina cinasa 2 activada por proteina cinasa activada por mitogeno (mk2) y sus usos.
MX2017007645A (es) Composiciones inhibidoras de nitrificacion y metodos para preparar las mismas.
EA033325B1 (ru) Ингибиторы бромодомена
PH12017502207A1 (en) Tau-binding antibodies
MX2019001352A (es) Hidroxiapatita permanentemente polarizada, proceso para su fabricación y sus usos.
NZ732402A (en) Nitrification inhibitor compositions and methods for preparing the same
EP3127865A4 (en) Powdered tobermorite type calcium silicate-based material and method for producing same
EP3102639C0 (en) SURFACE-TREATED CALCIUM CARBONATE, METHOD FOR PRODUCING THEREOF AND COMPOSITIONS THEREOF
IL268007A (en) Anti-TNF antibodies, preparations and methods for the treatment of active psoriatic arthritis
MY167711A (en) Cement additive, cement composition, and raw material for cement additive
MX2017000527A (es) Formulaciones de anticuerpos cristalinos.
MX2016010841A (es) Proceso para la preparacion de un producto rellenador mineral.
MX2021006003A (es) Formulaciones de anticuerpos cristalinos.
MX2017003219A (es) Derivados de tetrahidroquinolina como inihbidores de bromodominio.
MX2020003761A (es) Particulas solidas de simeticona y forma de dosificacion de estas.
PH12017501022B1 (en) Compositions comprising 15-hepe and methods of treating or preventing fibrosis using same
MX2016016613A (es) Composicion en forma de particulas compactadas y su uso.
MX2021000508A (es) Extracto de sabadilla seco y fluido.
MX2016013534A (es) Adsorcion y/o reduccion de la cantidad de materiales organicos en un medio acuoso con el uso de carbonato de calcio precipitado coloidal.